参考文献/References:
[1] 〖ZK(#〗李作君. 慢性肾脏病的流行现状与防治[J] . 临床合理用药杂志,2013,6(26):119119.
[2] 周浩明,杨军平. 慢性肾衰竭微血管的中西医保护机制研究进展[J] . 实用中西医结合临床,2016,16(11):9294.
[3] 白小洁. 血液透析病人的营养护理[J] . 中国中西医结合肾病杂志,2002(10):610611.
[4] Baliga R,George VT,Ray PE,et al. Effects of reduced renal function and dietary protein on muscle protein synthesis [J] . Kidney Int,1991,39(5):831835.
[5] Kim JK,Choi SR,Choi MJ,et al.Prevalence of and factors associated with sarcopenia in elderly pationts with endstage renal disease[J] .Clin Nutr,2014,33(1):6468.
[6] Hakim R M. Predictive measures of vascular access thrombosis:a prospective study.[J] . Kidney International,1997,52(6):16561662.
[7] 陈 昭,席焕久.人体测量方法[M].2版.北京:科学出版社,2010:4748.
[8] A Sayer A,Stewart C,Patel H,et al.The developmental origins of sarcopenia:from epidemiological evidence to underlying mechanisms[J] .J Dev Orig Health Dis,2010,1(3):150157.
[9] Domański M,Ciechanowski K. Sarcopenia:A major challenge in elderly patients with endstage renal disease[J] . Journal of Aging Research,2012,2012(10):754739. 〖ZK)〗
[10] 〖ZK(#〗Greco A,Paroni G,Seripa D,et al. Frailty,disability and physical exercise in the aging process and in chronic kidney disease [J] .Kidney Blood Press Res,2014,39(23):164168.
[11] Kim JC,KalantarZadeh K,Kopple JD. Frailty and proteinenergy wasting in elderly patients with end stage kidney disease\[J \]. J Am Soc Nephrol,2013,24(3):337351.
[12] 任红旗,龚德华.尿毒症肌少症的发病机制和治疗[J] .肾脏病与透析肾移植杂志,2015,24(2):181185.
[13] 黄丽娅,李少华,翁 敏,等. 维持性血液透析病人骨骼肌减少症发生率和危险因素研究[J] . 肠外与肠内营养,2017,24(2):7881.
[14] Mak RH,Ikizler AT,Kovesdy CP,et al.Wasting in chronic kidney disease[J] . Cachexia Sarcopenia Muscle,2011,2(1):925.
[15] 孙春晓,郭兆安. 慢性肾脏病血脂代谢紊乱的影响因素及其机制的研究进展[J] . 中国中西医结合肾病杂志,2014,(6):546548.
[16] 陶建瓴,李学旺. 慢性肾脏病脂质异常的治疗及意义[J] . 中国实用内科杂志,2010,30(10):872874.
[17] 余永武,杨峥维,张雅芳,等. 医院船就诊拉美3国人群中慢性肾脏疾病与脂质代谢的关系研究[J] . 西北国防医学杂志,2012,33(3):245247.
[18] Executive Summary of the third report of the nationalc holesteroleducation program ( NCEP ) . Expert panel on detection,evaluation,and treatment of high blood cholesterol in adults (AdultTreatm ent Panel III) [J] . JAMA,2001,285(1):2486 2497.
[19] Lipoproteins in maintaining cholesterol efflux from Fu5AH cells to plasma from insulinresistant subjects[J] .Scand J C lin Lab Invest,2001,61(1):6974.
[20] 宋春奇,刘 畅.生物时钟与脂肪组织代谢整合机制研究进展[J] .生命科学,2015,27(11):14181426.
相似文献/References:
[1]陈 昕,张 莹.血液透析联合血液灌流对尿毒症患者毒素清除率、炎性因子、钙磷代谢及免疫功能的影响*[J].陕西医学杂志,2019,(6):770.
CHEN Xin,ZHANG Ying.Effect of hemodialysis combined with hemoperfusion on toxin clearance rate,inflammatory factors, Calcium-phosphorus metabolism and immune function in patients with uremia[J].,2019,(9):770.
[2]罗孔认,陈梦诗,陈珊娜.甲壳质酶蛋白40、中性粒细胞载脂蛋白及基质金属蛋白酶-9水平与尿毒症维持性血液透析患者感染相关性研究[J].陕西医学杂志,2023,52(10):1362.[doi:DOI:10.3969/j.issn.1000-7377.2023.10.017]
LUO Kongren,CHEN Mengshi,CHEN Shanna.Correlation of YKL-40,NGAL and MMP-9 levels with infection in uremic patients undergoing maintenance hemodialysis[J].,2023,52(9):1362.[doi:DOI:10.3969/j.issn.1000-7377.2023.10.017]